Wu, Tong http://orcid.org/0000-0001-9968-9909
Lyu, Ruitu
You, Qiancheng
He, Chuan http://orcid.org/0000-0003-4319-7424
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01 HG006827, RM1 HG008935)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (P01 NS097206)
Article History
Received: 30 October 2019
Accepted: 2 March 2020
First Online: 6 April 2020
Change Date: 31 May 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41592-020-0881-1
Competing interests
: The University of Chicago has filed a patent application on KAS-seq. C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics, Inc., and a shareholder of Epican Genetech.